It is known that daily polyaspartic acid (PAA) protects the kidney from gentamicin nephrotoxicity in a standardized rat model despite marked cortical accumulation of the aminoglycoside. The present experiments address the duration of PAA protection. When administered every other day, PAA provided functional and histologic protection against gentamicin-induced toxicity. A stepwise reduction in nephroprotection occurred as the dosage interval was prolonged.
Daily coadministration of the polyanion polyaspartic acid (PAA) with gentamicin (G) prevents experimental nephrotoxicity despite marked aminoglycoside accumulation in the renal cortex (3, (10) (11) (12) . On the basis of both in vitro and in vivo studies, it is believed that PAA undergoes endocytosis by renal proximal tubular cells and then, at an intracellular location, forms complexes with the aminoglycoside prior to aminoglycoside-induced cell damage (1, 7, 11) . This postulated sequence is consistent with the very high renal concentrations of G in PAA-treated animals (3, 12 that of PAA or G given to other animals. Animals were divided into six groups (n = 4 in each): diluent only, PAA only, G only, daily G plus PAA every 48 h (PAA48), daily G plus PAA every 96 h (PAA96), and daily G plus PAA every 144 h (PAA144). Animals were treated for 7, 10, 14, 21, and 28 days. At sacrifice, blood was obtained for determination of the serum creatinine concentration by standard methods. One kidney from each animal was processed for light microscopy. The second kidney was digested as previously described (3) and assayed for G content by a polarized fluorescence immunoassay (Abbott TDX). The assay has a lower limit of sensitivity of 0.1 ,ug/ml with a coefficient of variation of 5%. The tissue assay standard curve is linear up to 5,000 ng/g of kidney cortex. Recovery studies showed greater than 90% yield using known standards. The renal histopathologic techniques have been described previously (3) . One pathologist evaluated all renal sections in a blinded fashion and reported the estimated percentage of necrotic and regenerating cortical tubular cells. Statistical analysis of the data was performed on an IBM-XT with the software program Abstat from Anderson-Bell, Parker, Colo. We used the ANOVA program which tests for significant differences among the means of up to four-way unequal n groups of data with Scheffe's post-hoc test with a significance level of 0.05. The program reports P values for all pairs which test below 0.05.
The serum creatinine results are summarized in Table 1 . G alone caused severe renal injury with detectable creatinine increases after 10 days, a mean value of 6.2 mg/dl after 14 days, and death of all animals, presumably due to uremia, thereafter. The serum creatinine values in PAA48 rats were no different from those in control animals at all time points. In the PAA96 and PAA144 groups serum creatinine concentrations returned toward normal values on days 21 and 28 following peak elevations on day 14. Histologically, the extent of tubular epithelial cell necrosis and regeneration was minimal in the PAA48 group, never exceeding 15%, in contrast to that in all other G-exposed animals ( Table 2 ). An inverse correlation appeared between the frequency of PAA dosing and tubular damage. The renal G concentration of rats given G alone fell in temporal concordance with the observed necrosis of tubular cells on days 10 and 14 (Table   3 ). PAA48 rats accumulated three to four times as much G in their renal parenchyma compared with G-alone rats. The pattern in PAA144 animals is of interest. After 10 days, renal G levels were three times higher than in G-alone rats. With the wave of necrosis on day 14, the renal G concentration fell to values approaching those observed in G-only animals.
Note that after 28 days, the renal G concentration more than doubled concomitant with a fall in the mean serum creatinine concentration to near that of controls.
The protective role of polyamino acids such as PAA in experimental aminoglycoside nephrotoxicity was initially described in 1985 (13) . In addition to PAA, a number of polyanionic compounds have been reported to confer nephroprotection in experimental models of aminoglycoside nephrotoxicity (2, 4-6, 8, 9, 13) . Coadministration of PAA and G provides functional and structural nephroprotection despite marked cortical accumulation of G. The mechanism which underlies the observed nephroprotection while allowing for the dissociation between nephrotoxicity and parenchymal G accumulation remains ill defined. It is tempting to hypothesize that intracellular inactivation of G by PAA prevents it from binding to one or more cellular organelles, precluding toxic injury. We previously reported complex formation between PAA and tobramycin in vitro (7) which was maximal at a pH of 5.0. In preliminary data, Ramsammy et al. reported nephroprotection when PAA was administered 16 h before G during an 8-day treatment period in rats (11) . This further supports an intracellular interaction between PAA and G. Nephroprotection does not require simultaneous administration of the two compounds; rather, providing a dosing window (i.e., 48 h) within which intracellular complexation of PAA and G occurs can confer complete functional and structural protection. Potentially, a standardized PAA preparation could function as an intracellular sponge for aminoglycosides, negating their nephrotoxic effects while maintaining antibacterial efficacy.
Difficulty arises when one attempts to incorporate PAA into clinical therapeutic regimens. To our knowledge, this report is the first to explore the duration of nephroprotection of PAA, functionally and histologically. it is of interest that the PAA preparations used in previous studies as well as the current formulation differ in terms of molecular weight; 16,000 and 3,700 (3, 12) versus 5,100 to 7,500. Thus, the relationship between molecular weight and nephroprotection, if one exists, remains undefined. Theoretically, it is the net negative charge of the polyanion and its electrostatic binding to the polycationic aminoglycoside intracellularly that confer nephroprotection. To date, all preparations of PAA chemically analyzed have represented mixtures of D and L enantiomers. It is likely that the presence of the D form of PAA is necessary for nephroprotection (unpublished data) by preventing or significantly slowing endogenous enzymatic breakdown. Presumably, the purified poly-D-aspartic acid preparation confers maximal protection and could potentially be given at significantly lower doses.
In conclusion, PAA when given every other day prevented functional and attenuated histologic renal injury induced by G in rats. The PAA dosage interval was extended to every 96 and every 144 h with a stepwise decrease in the amount of protection from renal injury. In rats given PAA, there was a correlation between the renal .G concentration and the degree of nephroprotection against aminoglycoside injury. 
